43.3 Percent of Children With Insomnia Have Persistent Trajectory
THURSDAY, Feb. 17, 2022 (HealthDay News) -- For children with insomnia symptoms, 43.3 percent have a persistent trajectory, according to a study published online Feb. 17 in Pediatrics.
Julio Fernandez-Mendoza, Ph.D., from the Penn State Health Milton S. Hershey Medical Center, and colleagues studied 502 children (median, 9 years old) 7.4 years later as adolescents (median, 16 years old), and 15 years later as adults (median, 24 years old) to examine the developmental trajectories of insomnia symptoms. At all three time points, insomnia symptoms were ascertained as moderate-to-severe difficulties initiating and/or maintaining sleep via parent or self reports.
The researchers found that the most frequent trajectory among children with insomnia symptoms was persistence (43.3 percent), followed by remission (26.9 and 11.2 percent since childhood and since adolescence, respectively) and a waxing-and-waning pattern (18.6 percent). The most frequent trajectory among children with normal sleep was persistence (48.1 percent), then developing insomnia symptoms (15.2 and 20.7 percent since adolescence and in adulthood, respectively) and a waxing-and-waning pattern (16.0 percent). Among short-sleeping children and adolescents, the odds of insomnia symptoms worsening into adult insomnia (22.0 percent of children and 20.8 percent of adolescents) were increased 2.6- and 5.5-fold, respectively.
"Pediatricians should consider adolescence a critical period for the adverse prognosis of insomnia symptoms, particularly for the insomnia with short sleep duration phenotype," the authors write. "Early sleep interventions are a priority, as clinicians should not expect insomnia symptoms to developmentally remit in a high proportion of children."
Abstract/Full Text (subscription or payment may be required)
Related Posts
Adherence to Quality Indicators Low in Chronic Myeloid Leukemia
WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- For newly diagnosed chronic-phase...
Pfizer Says Its Booster Shot Bolsters Immune Response in Those Aged 5 to 11 Years
THURSDAY, April 14, 2022 (HealthDay News) -- Pfizer Inc. said Thursday that its...
¿Los bebés que nacen por cesárea se quedan sin los microbios útiles de mamá? Quizá no
VIERNES, 10 de marzo de 2023 (HealthDay News) -- Unas nuevas evidencias...
Breastfeeding May Boost a Child’s Brainpower, Study Shows
THURSDAY, May 26, 2022 (HealthDay News) -- Breastfeeding has long been thought...